Valuation: Pharmena S.A.

Market Cap 35.2M 9.39M 8.21M 7.54M 7.03M 13.33M 894M 13.53M 90.54M 439M 35.23M 34.48M 1.51B P/E 2024
-33.8x
P/E 2025 -10.4x
Enterprise Value 35.2M 9.39M 8.21M 7.54M 7.03M 13.34M 894M 13.54M 90.56M 439M 35.24M 34.49M 1.51B EV / Sales 2024
154x
EV / Sales 2025 18.4x
Free-Float
29.7%
Yield 2024 *
-
Yield 2025 -
1 day+0.32%
1 week+2.60%
Current month+0.32%
1 month+0.64%
3 months-4.24%
6 months+19.25%
Current year+21.54%
1 week 3.06
Extreme 3.06
3.18
1 month 3.05
Extreme 3.05
3.3
Current year 2.56
Extreme 2.56
4.32
1 year 2.5
Extreme 2.5
4.32
3 years 2.5
Extreme 2.5
9.18
5 years 2.5
Extreme 2.5
13.7
10 years 2.5
Extreme 2.5
33.48
Manager TitleAgeSince
Chief Executive Officer - 12/11/2002
Chief Tech/Sci/R&D Officer - 01/04/2008
Director TitleAgeSince
Director/Board Member 62 -
Director/Board Member 63 -
Director/Board Member 58 -
Change 5-day change 1-year change 3-year change Capi.($)
+0.32%+2.60%0.00%-55.87% 9.39M
-1.42%-1.43%+3.38%-9.80% 234B
-0.42%+0.73%+53.07% - 52.42B
-4.85%+5.37%+177.58% - 9.36B
+2.10%+7.60%+5.41%-57.67% 6.86B
+1.51%+24.95%-9.28%+23.93% 4.9B
-2.96%+13.33%-41.66%-32.52% 4.54B
+3.22%+10.58%-13.83%-12.94% 3.82B
+1.70%+5.66%-26.04%-46.41% 3.46B
-0.07%+6.39%-21.84%-49.85% 2.58B
Average -0.09%+5.94%+12.68%-30.14% 32.15B
Weighted average by Cap. -1.16%-0.14%+15.04%-11.76%

Financials

2024 2025
Net sales 268K 71.48K 62.49K 57.42K 53.53K 102K 6.81M 103K 689K 3.35M 268K 263K 11.53M 1.58M 421K 368K 338K 315K 597K 40.05M 606K 4.06M 19.69M 1.58M 1.54M 67.83M
Net income -1.26M -337K -294K -270K -252K -478K -32.05M -485K -3.25M -15.75M -1.26M -1.24M -54.28M -2.77M -739K -646K -593K -553K -1.05M -70.32M -1.06M -7.12M -34.56M -2.77M -2.71M -119M
Net Debt -1.5M -400K -350K -322K -300K -569K -38.12M -577K -3.86M -18.74M -1.5M -1.47M -64.56M 9K 2.4K 2.1K 1.93K 1.8K 3.41K 229K 3.46K 23.15K 112K 9.01K 8.82K 387K
Logo Pharmena S.A.
Pharmena SA is a Poland-based producer of cosmetics and pharmaceuticals. The Company’s products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.
Employees
7
Date Price Change Volume
03/07/26 PLN 3.160 +0.32% 85
02/07/26 PLN 3.150 -0.32% 435
01/07/26 PLN 3.160 +0.32% 231
30/06/26 PLN 3.150 -0.63% 1,008
29/06/26 PLN 3.170 +2.92% 1,597